Phosphoramide mustard
CAS No. 10159-53-2
Phosphoramide mustard( —— )
Catalog No. M35039 CAS No. 10159-53-2
Phosphoramide mustard is a toxic metabolite of cyclophosphamide with anticancer activity and ovarian toxicity that induces DNA damage.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 445 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NamePhosphoramide mustard
-
NoteResearch use only, not for human use.
-
Brief DescriptionPhosphoramide mustard is a toxic metabolite of cyclophosphamide with anticancer activity and ovarian toxicity that induces DNA damage.
-
DescriptionPhosphoramide mustard is a biologically active metabolite of Cyclophosphamide (HY-17420), with anticancer activitiy. Phosphoramide mustard induces DNA damage.
-
In VitroPhosphoramide mustard causes cytotoxicity through forming cross-linked DNA adducts which inhibit DNA strand separation during replication.Phosphoramide mustard (3-6 μM; 48 hours) reduces cell viability in rat spontaneously immortalized granulosa cells (SIGCs).Phosphoramide mustard (3-6 μM; 24-48 hours) induces DNA adduct formation and ovarian DNA damage.Phosphoramide mustard (3-6 μM; 24-48 hours) increases DNA damage responses (DDR) gene mRNA expression levels and DDR proteins.Cell Viability Assay Cell Line:SIGCs Concentration:0.5 μM, 1 μM, 3 μM, 6 μM Incubation Time:48 hours Result:Reduced cell viability at concentrations of 3 μM and higher.RT-PCR Cell Line:SIGCs Concentration:3 μM, 6 μM Incubation Time:24 hours, 48 hours Result:Increased DDR gene mRNA expression levels. Western Blot Analysis Cell Line:SIGCs Concentration: 3 μM, 6 μM Incubation Time:24 hours, 48 hours Result:Generally increased DDR proteins.
-
In VivoPhosphoramide mustard (2.1-20.7 mg/kg; i.p.; daily; for 5 days) inhibits subcutaneous tumor growth in rats.Phosphoramide mustard exhibits terminal elimination half-lives (rat 15.1 min) following intravenous administration (rat 59.4 mg/kg).Animal Model:Rat, subcutaneously implanted Walker 256 carcinosarcoma tumorDosage:2.1 mg/kg, 4.8 mg/kg, 10.4 mg/kg, 20.7 mg/kg Administration:Intraperitoneal injection, once daily, for 5 consecutive days Result:Required to produce 50% inhibition of subcutaneous tumor growth with dose of 12 mg/kg.Animal Model:Rats Dosage:59.4 mg/kg (Pharmacokinetic Analysis)Administration:Intravenous injection Result:T1/2 (15.1 min).
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorDrug Metabolite | DNA Alkylation
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number10159-53-2
-
Formula Weight221.02
-
Molecular FormulaC4H11Cl2N2O2P
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=P(O)(N)N(CCCl)CCCl
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
Toringin
Toringin, a bioflavonoid, is isolated from the bark of Docyniopsis tschonoski. Toringin progressively decreases not only the cis-effect of the expanded CTG repeats but cytotoxicity as well. Exposure to isosakuranetin, Toringin rescues PC12 neuronal cells. Flavonoids are efficacious for ameliorating the RNA gain of function caused by expanded CTG repeats, and have various biological activities and beneficial actions against cancers, coronary heart disease, among other pathologies.
-
Vapreotide
Vapreotide is a neurokinin-1 (NK1) receptor antagonist, with an IC50 of 330 nM.
-
Cinnamic aldehyde
Cinnamic aldehyde exhibits excellent anti-inflammatory activities and antidepressant-like effects in stressed mid-aged rats as a COX-2 inhibitor.
Cart
sales@molnova.com